Robotic nanoparticle delivery systems for tumor hyperthermia: clinical readiness and challenges

Robotic nanoparticle delivery systems for tumor hyperthermia are redefining precision oncology. By integrating magnetic nanoparticles, robotics, and real-time imaging, these systems enable controlled heating of malignant tissue while sparing adjacent structures. Magnetic nanoparticle hyperthermia employs iron oxide nanoparticles activated by alternating magnetic fields to generate localized heat. Advances in Korea, Germany, and China demonstrate the effectiveness of microrobots and magnetic swarms in enhancing nanoparticle targeting and uniform thermal deposition. Image-guided robotic systems with MRI and ultrasound thermometry further optimize safety and reproducibility. Clinically, Germany's MagForce Nanotherm® device is approved for glioblastoma, with ongoing international trials in prostate and pancreatic cancers. However, consistent dosing, nanoparticle biosafety, and standardized protocols remain pressing challenges. With cross-disciplinary collaboration, robotic hyperthermia could soon become a minimally invasive, targeted option for complex solid tumors. This emerging field underscores the need for ethical transparency and adherence to reporting standards for artificial intelligence in medical technology development.